2021-2022 Regular Session • US Congress Legislature
HB5260: Reduced Costs and Continued Cures Act
Legislative Summary
To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
Bill History
9/14/2021
Introduced in House
House of Representatives
9/14/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
9/14/2021
Referred to the Subcommittee on Health.
House of Representatives
11/1/2022
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
House of Representatives
11/1/2022
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
House of Representatives
Status Information
Current Status
Introduced(9/14/2021)
Chamber
House of Representatives
Committee
Subcommittee on Courts, Intellectual Property, And The Internet(House of Representatives)
Sponsors
Democrat: 6
Primary Sponsor
Scott Peters
Democrat